Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.

Recruiting N/A Interventional Study
Active Cancer and Symptomatic or Incidental Pulmonary Embolism Without HESTIA Criteria
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
824 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Main objective of this multisite randomised study aims to demonstrate in patients with active cancer and symptomatic or incidental PE without HESTIA criteria, that home treatment is non-inferior to hospitalisation as regards the 14-day rate of the composite primary endpoint. Primary endpoint corresponds to the rate of the composite of centrally adjudicated recurrent incidental or symptomatic VTE …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Symptomatic or incidental hemodynamically stable PE objectively confirmed ≤ 24h according to the ESC guidelines * Active cancer other than basal-cell or squamous-cell carcinoma of the skin defined at least by one of the followings: * cancer that has been diagn…
Contacts

Cleo BOURGEOIS

+33156095638

cleo.bourgeois@aphp.fr

CONTACT